Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

Name: Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

constitutional mismatch repair deficiency syndrome, lynch syndrome, malignant glioma, recurrent brain neoplasm, recurrent childhood ependymoma, recurrent diffuse intrinsic pontine glioma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 329530
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.